Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck & Co., Inc. Lawsuit - MRK
Portfolio Pulse from
Levi & Korsinsky law firm is pursuing a class action securities lawsuit against Merck & Co., alleging securities fraud related to Gardasil sales projections in China. The lawsuit claims Merck misrepresented expected revenue of $11 billion by 2030, with the stock dropping over 9% after announcing it would cease Gardasil shipments to China midyear due to lower-than-expected demand.
March 27, 2025 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Merck is confronting a class action lawsuit alleging securities fraud related to Gardasil sales forecasts, which could result in financial penalties and investor trust erosion.
The lawsuit directly targets Merck's representations about Gardasil sales, alleging material misstatements that caused investor losses. The 9% stock drop and potential legal consequences suggest negative short-term implications.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100